✦ LIBER ✦

53 Lung function, weight, and sweat chloride responses in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor: A secondary analysis

✍ Scribed by Plant, B.J.; Konstan, M.; Aherns, R.; Rodriguez, S.; Munck, A.; Elborn, J.S.; Johnson, C.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of clinical response to ivaca

✍ Davies, Jane; Sheridan, Helen; Bell, Nicholas; Cunningham, Steve; Davis, Stephan 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 423 KB

WS1.1 The effect of ivacaftor, a CFTR po

✍ De Boeck, K.; Munck, A.; Walker, S.; Faro, A.; Hiatt, P.; Chan, J.; Gilmartin, G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 70 KB

57 Ivacaftor in French patients with cys

✍ Hubert, D.; David, V.; Rault, G.; Dominique, S.; Mély, L.; Munck, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB

WS23.3 ICM is sensitive to detect potent

✍ Graeber, S.Y.; Hug, M.J.; Sommerburg, O.; Mainz, J.G.; Heinzmann, A.; Tümmler, B 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

WS3.2 The effect of ivacaftor treatment

✍ Altes, T.; Johnson, M.; Higgins, M.; Fidler, M.; Botfield, M.; Mugler III, J.P.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 68 KB

WS7.6 Effect of ivacaftor on lung functi

✍ J.C. Davies; H. Sheridan; P.-S. Lee; T. Song; A. Stone; F. Ratjen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB